title: Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
authors.forename: Javier P
authors.initials: JP
authors.lastname: Gisbert
authors.forename: Miguel Fernández
authors.initials: MF
authors.lastname: Bermejo
authors.forename: Javier Molina
authors.initials: JM
authors.lastname: Infante
authors.forename: Belén Pérez
authors.initials: BP
authors.lastname: Gallardo
authors.forename: Ana-Beatriz Prieto
authors.initials: AB
authors.lastname: Bermejo
authors.forename: José-María Mateos
authors.initials: JM
authors.lastname: Rodríguez
authors.forename: Pilar Robledo
authors.initials: PR
authors.lastname: Andrés
authors.forename: Guadalupe González
authors.initials: GG
authors.lastname: García
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010349:Patient Compliance; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D064704:Levofloxacin; D000658:Amoxicillin; D015242:Ofloxacin; D009853:Omeprazole